カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のニボルマブ薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Nivolumab Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19462）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19462
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：77
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のニボルマブ薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ニボルマブ薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のニボルマブ薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ニボルマブ薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・10ml、4ml、24ml

用途別セグメントは次のように区分されます。
・小売薬局、病院薬局、その他

世界のニボルマブ薬市場の主要な市場プレーヤーは以下のとおりです。
・Bristol-Myers Squibb、Ono Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ニボルマブ薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なニボルマブ薬メーカーの企業概要、2019年～2022年までのニボルマブ薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なニボルマブ薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ニボルマブ薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのニボルマブ薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのニボルマブ薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびニボルマブ薬の産業チェーンを掲載しています。
・第13、14、15章では、ニボルマブ薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ニボルマブ薬の概要
- 種類別分析（2017年vs2021年vs2028年）：10ml、4ml、24ml
- 用途別分析（2017年vs2021年vs2028年）：小売薬局、病院薬局、その他
- 世界のニボルマブ薬市場規模・予測
- 世界のニボルマブ薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Bristol-Myers Squibb、Ono Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：10ml、4ml、24ml
・用途別分析2017年-2028年：小売薬局、病院薬局、その他
・ニボルマブ薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ニボルマブ薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ニボルマブ薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ニボルマブ薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ニボルマブ薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Nivolumab Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nivolumab Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Retail Pharmacy accounting for % of the Nivolumab Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 10ml segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Nivolumab Drugs include Bristol-Myers Squibb, Ono Pharmaceutical, , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nivolumab Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
10ml
4ml
24ml
Market segment by Application can be divided into
Retail Pharmacy
Hospital Pharmacy
Other
The key market players for global Nivolumab Drugs market are listed below:
Bristol-Myers Squibb
Ono Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nivolumab Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nivolumab Drugs, with price, sales, revenue and global market share of Nivolumab Drugs from 2019 to 2022.
Chapter 3, the Nivolumab Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nivolumab Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nivolumab Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nivolumab Drugs.
Chapter 13, 14, and 15, to describe Nivolumab Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Nivolumab Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nivolumab Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 10ml
1.2.3 4ml
1.2.4 24ml
1.3 Market Analysis by Application
1.3.1 Overview: Global Nivolumab Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Global Nivolumab Drugs Market Size & Forecast
1.4.1 Global Nivolumab Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nivolumab Drugs Sales in Volume (2017-2028)
1.4.3 Global Nivolumab Drugs Price (2017-2028)
1.5 Global Nivolumab Drugs Production Capacity Analysis
1.5.1 Global Nivolumab Drugs Total Production Capacity (2017-2028)
1.5.2 Global Nivolumab Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nivolumab Drugs Market Drivers
1.6.2 Nivolumab Drugs Market Restraints
1.6.3 Nivolumab Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Nivolumab Drugs Product and Services
2.1.4 Bristol-Myers Squibb Nivolumab Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Ono Pharmaceutical
2.2.1 Ono Pharmaceutical Details
2.2.2 Ono Pharmaceutical Major Business
2.2.3 Ono Pharmaceutical Nivolumab Drugs Product and Services
2.2.4 Ono Pharmaceutical Nivolumab Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Nivolumab Drugs Breakdown Data by Manufacturer
3.1 Global Nivolumab Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nivolumab Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nivolumab Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Nivolumab Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Nivolumab Drugs Manufacturer Market Share in 2021
3.5 Global Nivolumab Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nivolumab Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nivolumab Drugs Market Size by Region
4.1.1 Global Nivolumab Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Nivolumab Drugs Revenue by Region (2017-2028)
4.2 North America Nivolumab Drugs Revenue (2017-2028)
4.3 Europe Nivolumab Drugs Revenue (2017-2028)
4.4 Asia-Pacific Nivolumab Drugs Revenue (2017-2028)
4.5 South America Nivolumab Drugs Revenue (2017-2028)
4.6 Middle East and Africa Nivolumab Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Nivolumab Drugs Sales in Volume by Type (2017-2028)
5.2 Global Nivolumab Drugs Revenue by Type (2017-2028)
5.3 Global Nivolumab Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Nivolumab Drugs Sales in Volume by Application (2017-2028)
6.2 Global Nivolumab Drugs Revenue by Application (2017-2028)
6.3 Global Nivolumab Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Nivolumab Drugs Sales by Type (2017-2028)
7.2 North America Nivolumab Drugs Sales by Application (2017-2028)
7.3 North America Nivolumab Drugs Market Size by Country
7.3.1 North America Nivolumab Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Nivolumab Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Nivolumab Drugs Sales by Type (2017-2028)
8.2 Europe Nivolumab Drugs Sales by Application (2017-2028)
8.3 Europe Nivolumab Drugs Market Size by Country
8.3.1 Europe Nivolumab Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Nivolumab Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Nivolumab Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Nivolumab Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Nivolumab Drugs Market Size by Region
9.3.1 Asia-Pacific Nivolumab Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nivolumab Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Nivolumab Drugs Sales by Type (2017-2028)
10.2 South America Nivolumab Drugs Sales by Application (2017-2028)
10.3 South America Nivolumab Drugs Market Size by Country
10.3.1 South America Nivolumab Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Nivolumab Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nivolumab Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Nivolumab Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Nivolumab Drugs Market Size by Country
11.3.1 Middle East & Africa Nivolumab Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nivolumab Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Nivolumab Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nivolumab Drugs
12.3 Nivolumab Drugs Production Process
12.4 Nivolumab Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nivolumab Drugs Typical Distributors
13.3 Nivolumab Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Nivolumab Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Nivolumab Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Major Business
Table 5. Bristol-Myers Squibb Nivolumab Drugs Product and Services
Table 6. Bristol-Myers Squibb Nivolumab Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Ono Pharmaceutical Major Business
Table 9. Ono Pharmaceutical Nivolumab Drugs Product and Services
Table 10. Ono Pharmaceutical Nivolumab Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Global Nivolumab Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 12. Global Nivolumab Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 13. Market Position of Manufacturers in Nivolumab Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 14. Global Nivolumab Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 15. Head Office and Nivolumab Drugs Production Site of Key Manufacturer
Table 16. Nivolumab Drugs New Entrant and Capacity Expansion Plans
Table 17. Nivolumab Drugs Mergers & Acquisitions in the Past Five Years
Table 18. Global Nivolumab Drugs Sales by Region (2017-2022) & (K Units)
Table 19. Global Nivolumab Drugs Sales by Region (2023-2028) & (K Units)
Table 20. Global Nivolumab Drugs Revenue by Region (2017-2022) & (USD Million)
Table 21. Global Nivolumab Drugs Revenue by Region (2023-2028) & (USD Million)
Table 22. Global Nivolumab Drugs Sales by Type (2017-2022) & (K Units)
Table 23. Global Nivolumab Drugs Sales by Type (2023-2028) & (K Units)
Table 24. Global Nivolumab Drugs Revenue by Type (2017-2022) & (USD Million)
Table 25. Global Nivolumab Drugs Revenue by Type (2023-2028) & (USD Million)
Table 26. Global Nivolumab Drugs Price by Type (2017-2022) & (US$/Unit)
Table 27. Global Nivolumab Drugs Price by Type (2023-2028) & (US$/Unit)
Table 28. Global Nivolumab Drugs Sales by Application (2017-2022) & (K Units)
Table 29. Global Nivolumab Drugs Sales by Application (2023-2028) & (K Units)
Table 30. Global Nivolumab Drugs Revenue by Application (2017-2022) & (USD Million)
Table 31. Global Nivolumab Drugs Revenue by Application (2023-2028) & (USD Million)
Table 32. Global Nivolumab Drugs Price by Application (2017-2022) & (US$/Unit)
Table 33. Global Nivolumab Drugs Price by Application (2023-2028) & (US$/Unit)
Table 34. North America Nivolumab Drugs Sales by Country (2017-2022) & (K Units)
Table 35. North America Nivolumab Drugs Sales by Country (2023-2028) & (K Units)
Table 36. North America Nivolumab Drugs Revenue by Country (2017-2022) & (USD Million)
Table 37. North America Nivolumab Drugs Revenue by Country (2023-2028) & (USD Million)
Table 38. North America Nivolumab Drugs Sales by Type (2017-2022) & (K Units)
Table 39. North America Nivolumab Drugs Sales by Type (2023-2028) & (K Units)
Table 40. North America Nivolumab Drugs Sales by Application (2017-2022) & (K Units)
Table 41. North America Nivolumab Drugs Sales by Application (2023-2028) & (K Units)
Table 42. Europe Nivolumab Drugs Sales by Country (2017-2022) & (K Units)
Table 43. Europe Nivolumab Drugs Sales by Country (2023-2028) & (K Units)
Table 44. Europe Nivolumab Drugs Revenue by Country (2017-2022) & (USD Million)
Table 45. Europe Nivolumab Drugs Revenue by Country (2023-2028) & (USD Million)
Table 46. Europe Nivolumab Drugs Sales by Type (2017-2022) & (K Units)
Table 47. Europe Nivolumab Drugs Sales by Type (2023-2028) & (K Units)
Table 48. Europe Nivolumab Drugs Sales by Application (2017-2022) & (K Units)
Table 49. Europe Nivolumab Drugs Sales by Application (2023-2028) & (K Units)
Table 50. Asia-Pacific Nivolumab Drugs Sales by Region (2017-2022) & (K Units)
Table 51. Asia-Pacific Nivolumab Drugs Sales by Region (2023-2028) & (K Units)
Table 52. Asia-Pacific Nivolumab Drugs Revenue by Region (2017-2022) & (USD Million)
Table 53. Asia-Pacific Nivolumab Drugs Revenue by Region (2023-2028) & (USD Million)
Table 54. Asia-Pacific Nivolumab Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Asia-Pacific Nivolumab Drugs Sales by Type (2023-2028) & (K Units)
Table 56. Asia-Pacific Nivolumab Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Asia-Pacific Nivolumab Drugs Sales by Application (2023-2028) & (K Units)
Table 58. South America Nivolumab Drugs Sales by Country (2017-2022) & (K Units)
Table 59. South America Nivolumab Drugs Sales by Country (2023-2028) & (K Units)
Table 60. South America Nivolumab Drugs Revenue by Country (2017-2022) & (USD Million)
Table 61. South America Nivolumab Drugs Revenue by Country (2023-2028) & (USD Million)
Table 62. South America Nivolumab Drugs Sales by Type (2017-2022) & (K Units)
Table 63. South America Nivolumab Drugs Sales by Type (2023-2028) & (K Units)
Table 64. South America Nivolumab Drugs Sales by Application (2017-2022) & (K Units)
Table 65. South America Nivolumab Drugs Sales by Application (2023-2028) & (K Units)
Table 66. Middle East & Africa Nivolumab Drugs Sales by Region (2017-2022) & (K Units)
Table 67. Middle East & Africa Nivolumab Drugs Sales by Region (2023-2028) & (K Units)
Table 68. Middle East & Africa Nivolumab Drugs Revenue by Region (2017-2022) & (USD Million)
Table 69. Middle East & Africa Nivolumab Drugs Revenue by Region (2023-2028) & (USD Million)
Table 70. Middle East & Africa Nivolumab Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Middle East & Africa Nivolumab Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Middle East & Africa Nivolumab Drugs Sales by Application (2017-2022) & (K Units)
Table 73. Middle East & Africa Nivolumab Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Nivolumab Drugs Raw Material
Table 75. Key Manufacturers of Nivolumab Drugs Raw Materials
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Nivolumab Drugs Typical Distributors
Table 79. Nivolumab Drugs Typical Customers
List of Figures
Figure 1. Nivolumab Drugs Picture
Figure 2. Global Nivolumab Drugs Revenue Market Share by Type in 2021
Figure 3. 10ml
Figure 4. 4ml
Figure 5. 24ml
Figure 6. Global Nivolumab Drugs Revenue Market Share by Application in 2021
Figure 7. Retail Pharmacy
Figure 8. Hospital Pharmacy
Figure 9. Other
Figure 10. Global Nivolumab Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Nivolumab Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Nivolumab Drugs Sales (2017-2028) & (K Units)
Figure 13. Global Nivolumab Drugs Price (2017-2028) & (US$/Unit)
Figure 14. Global Nivolumab Drugs Production Capacity (2017-2028) & (K Units)
Figure 15. Global Nivolumab Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Nivolumab Drugs Market Drivers
Figure 17. Nivolumab Drugs Market Restraints
Figure 18. Nivolumab Drugs Market Trends
Figure 19. Global Nivolumab Drugs Sales Market Share by Manufacturer in 2021
Figure 20. Global Nivolumab Drugs Revenue Market Share by Manufacturer in 2021
Figure 21. Nivolumab Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Nivolumab Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Nivolumab Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Nivolumab Drugs Sales Market Share by Region (2017-2028)
Figure 25. Global Nivolumab Drugs Revenue Market Share by Region (2017-2028)
Figure 26. North America Nivolumab Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Europe Nivolumab Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Nivolumab Drugs Revenue (2017-2028) & (USD Million)
Figure 29. South America Nivolumab Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Nivolumab Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Global Nivolumab Drugs Sales Market Share by Type (2017-2028)
Figure 32. Global Nivolumab Drugs Revenue Market Share by Type (2017-2028)
Figure 33. Global Nivolumab Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Nivolumab Drugs Sales Market Share by Application (2017-2028)
Figure 35. Global Nivolumab Drugs Revenue Market Share by Application (2017-2028)
Figure 36. Global Nivolumab Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Nivolumab Drugs Sales Market Share by Type (2017-2028)
Figure 38. North America Nivolumab Drugs Sales Market Share by Application (2017-2028)
Figure 39. North America Nivolumab Drugs Sales Market Share by Country (2017-2028)
Figure 40. North America Nivolumab Drugs Revenue Market Share by Country (2017-2028)
Figure 41. United States Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Nivolumab Drugs Sales Market Share by Type (2017-2028)
Figure 45. Europe Nivolumab Drugs Sales Market Share by Application (2017-2028)
Figure 46. Europe Nivolumab Drugs Sales Market Share by Country (2017-2028)
Figure 47. Europe Nivolumab Drugs Revenue Market Share by Country (2017-2028)
Figure 48. Germany Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Nivolumab Drugs Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Nivolumab Drugs Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Nivolumab Drugs Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Nivolumab Drugs Revenue Market Share by Region (2017-2028)
Figure 57. China Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Nivolumab Drugs Sales Market Share by Type (2017-2028)
Figure 64. South America Nivolumab Drugs Sales Market Share by Application (2017-2028)
Figure 65. South America Nivolumab Drugs Sales Market Share by Country (2017-2028)
Figure 66. South America Nivolumab Drugs Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Nivolumab Drugs Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Nivolumab Drugs Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Nivolumab Drugs Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Nivolumab Drugs Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Nivolumab Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Nivolumab Drugs in 2021
Figure 78. Manufacturing Process Analysis of Nivolumab Drugs
Figure 79. Nivolumab Drugs Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のオシメルチニブ医薬品市場2022年：市場規模予測（～2028年）
  • 世界のエクセナチド薬物市場2022年：市場規模予測（～2028年）
  • 世界のペガスパルガーゼ薬物市場2022年：市場規模予測（～2028年）
  • 世界のリロナセプト薬物市場2022年：市場規模予測（～2028年）
  • 世界のブリナツモマブ治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19462 )"世界のニボルマブ薬市場2022年：市場規模予測（～2028年）" (英文：Global Nivolumab Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。